Get started
Author

I. Miklya

Observed names: I Miklya, Iidikó Miklya
OpenAlex ID: A5113539152
Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this difference
1994 · J. Knoll, T.T. Yen, et al. · Life Sciences · 41
The significance of selegiline/(−)-deprenyl after 50 years in research and therapy (1965–2015)
2016 · I Miklya · Molecular Psychiatry · 39
PDF
Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition.
1995 · J Knoll, I Miklya · PubMed · 28
A pharmacological analysis elucidating why, in contrast to (-)-deprenyl (selegiline), α-tocopherol was ineffective in the DATATOP study
2003 · I Miklya, B Knoll, et al. · Life Sciences · 16
Analysis of the analgesic and anti-inflammatory effects of rimazolium, a pyrido-pyrimidine derivative, compared with that of prostaglandin synthesis inhibitors and morphine.
1985 · K Gyires, S Fürst, et al. · PubMed · 15
Longevity study with low doses of selegiline/(−)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP)
2016 · J. Knoll, I. Miklya · Life Sciences · 14
Analysis of the effect of (-)-BPAP, a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain
2003 · I Miklya, J Knoll · Life Sciences · 12
A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain
2017 · J. Knoll, K. Baghy, et al. · Life Sciences · 8
An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats
2003 · I Miklya, B Knoll, et al. · Life Sciences · 7
The fate of (−)1-(benzofuran-2-yl)-2-propylaminopentane · HCl, (−)-BPAP, in rats, a potent enhancer of the impulse-evoked release of catecholamines and serotonin in the brain
2002 · Kálmán Magyar, Joseph Lengyel, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2
A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam.
1990 · I Miklya, J Knoll · PubMed · 2
Chronic treatment with enhancer drugs modifies the gene expression of selected parameters related to brain plasticity in rats under stress conditions
2022 · K. Hrivikova, D. Zelena, et al. · Neurochemistry International · 1
低用量セレギリン/( )‐デプレニルおよび(2R)‐1-(1-ベンゾフラン-2-イル)-N-プロピルペンタン-2-アミン(BPAP)の寿命研究【Powered by NICT】
2016 · J Knoll, I Miklya · Life Sciences
Treatment possibilities of Alzheimer's disease.
2004 · I Miklya, P Gaszner · PubMed
Single, small dose administration of (-)methamphetamine (MA) and (-)deprenyl (D), in contrast to (+)MA enhances catecholaminergic activity and diminishes serotoninergic activity in the brain stem of rats
1995 · I. Miklya, J. Knoll · Pharmacological Research
Preparation of highly purified bovine liver angiohypotensin by HPLC
1992 · I. Miklya, D. Rácz, et al. · Pharmacological Research
Analysis of bovine liver angiohypotensin (AH) with HPLC purity on smooth muscle preparations
1992 · D. Rácz, I. Miklya, et al. · Pharmacological Research
3-amino-4-ethylthio-7-Cl-quinoline.HCl (EGIS 5278), a benzodiazepine receptor related new spectrum anxiolytic
1990 · I. Miklya, D. Rácz, et al. · European Journal of Pharmacology
The dose-related hypotensive effect of highly purified bovine liver angiohypotensin in narcotized normotensive rats.
1990 · I Faragó, I Miklya, et al. · PubMed
A new spectrum anxiolytic: 3-amino-4-ethylthio-7-Cl-quinoline. HCL (EGIS 5278).
1990 · I Miklya, D Berényi, et al. · PubMed
The selectivity of highly purified bovine liver angiohypotensin towards resistance vessels.
1990 · I Kovács, I Miklya, et al. · PubMed
Elaboration of highly purified angiohypotensin preparations from mammalian liver.
1990 · D Rácz, I Miklya, et al. · PubMed
Works count: 22
Citation count: 185
H-index: 8
I10-index: 7
Year
Topic
Type